SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-162560
Filing Date
2017-05-08
Accepted
2017-05-08 16:05:02
Documents
3
Period of Report
2017-05-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d394880d8k.htm 8-K 16894
2 EX-10.1 d394880dex101.htm EX-10.1 9119
3 GRAPHIC g394880g0506111105747.jpg GRAPHIC 6174
  Complete submission text file 0001193125-17-162560.txt   35917
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 17822202
SIC: 2834 Pharmaceutical Preparations